D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice
Nutrients · 2026
DOI: 10.3390/nu18040707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Yermek Rakhat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Integrative Physiology, Center for Integrative Physiology, Kansai Electric Power Medical Research Institute, Osaka 553-0003, Japan. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Obesity, Fructose, Hand Strength. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS), Gifu University, Japan Association for Diabetes Education and Care.
Abstract (Originalsprache)
Background
Rare sugar D-Allulose, a zero-calorie sweetener, markedly ameliorates obesity. It reportedly stimulates the release of endogenous glucagon-like peptide 1 (GLP-1) to activate vagal afferent and directly influences the neurons in hypothalamic arcuate nucleus (ARH), thus evoking vagal and central nervous routes. D-Allulose can now be produced substantially, being expected for diet therapy. Oral form GLP-1 receptor agonist (GLP-1RA), Oral semaglutide (O-Sema), without injection markedly ameliorates obesity. It evokes only central nervous route. Thus, these GLP-1-based substances utilize common/distinct routes, suggesting common/distinct effects on obesity and related disorders including sarcopenia. To address it, this study precisely compared their effects.
Methods
O-Sema and D-Allulose were administered to diet-induced obese mice under identical conditions, equivalent doses, oral gavage, and food/water deprivation. Acute and sub-chronic effects on food intake, body weight and grip strength were measured.
Results
Acutely, D-Allulose rapidly and O-Sema slowly reduced feeding. Sub-chronically, D-Allulose and O-Sema profoundly reduced food intake and weight in the early period (0–3 days) of treatment. The weight loss was diminished with O-Sema but maintained with D-Allulose in the late period (4–10 days) and after termination of treatment. D-Allulose and O-Sema increased muscle strength. Mechanistically, D-Allulose and semaglutide similarly activated anorexigenic leptin-responsive neurons while only D-Allulose significantly inhibited orexigenic ghrelin-responsive neurons in ARH.
Conclusions
D-Allulose and O-Sema equally elicit weight reduction possibly via the central nervous route including ARH anorexigenic neuron activation. The weight loss is rebounded with O-Sema, while it is maintained with D-Allulose possibly via combined vagal afferent and central nervous routes including ARH orexigenic neuron inhibition. Their optimal use potentially provides precise control of obesity and related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Integrative Physiology, Center for Integrative Physiology, Kansai Electric Power Medical Research Institute, Osaka 553-0003, Japan.
- Department of Diabetes, Endocrinology and Metabolism/Rheumatology and Clinical Immunology, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan.
- Departments of Diabetes Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
- Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Osaka 553-0003, Japan.
- Laboratory of Animal Functional Science, Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto 606-8522, Japan.
- Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu 501-1194, Japan.
ORCID-Profile: Yermek Rakhat, Seiya Banno, Dauren Zhantleu, Daisuke Yabe, Yusaku Iwasaki, Toshihiko Yada
Förderung
- Japan Society for the Promotion of Science (JSPS)
- Gifu University
- Japan Association for Diabetes Education and Care
- COMIT Collaborative Research 2024
- Japan Association for Diabetes Education and Care (JADEC) 2024
- Matsutani Chemical Industry Co.
Zitieren
APA
Rakhat, Y., Banno, S., Zhantleu, D., Tsunekawa, S., Yabe, D., Seino, Y., Iwasaki, Y., & Yada, T. (2026). D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice. Nutrients. https://doi.org/10.3390/nu18040707
Vancouver
Rakhat Y, Banno S, Zhantleu D, Tsunekawa S, Yabe D, Seino Y, et al. D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice. Nutrients. 2026. doi:10.3390/nu18040707
BibTeX
@article{Rakhat2026,
author = {Rakhat, Yermek and Banno, Seiya and Zhantleu, Dauren and Tsunekawa, Shin and Yabe, Daisuke and Seino, Yutaka and Iwasaki, Yusaku and Yada, Toshihiko},
title = {D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18040707}
}
EUVIMED